跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PDP-AMLODIPINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PDP-AMLODIPINE
Authorized
STANDARD
PDP-AMLODIPINE
pendopharm division of pharmascience inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
58929c4148ff2c44
Company
pendopharm division of pharmascience inc
Type
Standard
Approval Details
Approval Id
58929c4148ff2c44
Drug Approval Canada Name
PDP-AMLODIPINE
Product Name
PDP-AMLODIPINE
Status
Marketed
Status Date
2019-08-28
Original Market Date
2019-08-28
Din
02484706
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.08
Atc Original
C08CA01 AMLODIPINE
Atc Name
c 08 ca 01
Aig Number
0131437004
Company Name
pendopharm division of pharmascience inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Active Ingredients
AMLODIPINE (AMLODIPINE BESYLATE)
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
58929c4148ff2c44
Type
Standard
Back to Health Canada Approvals